Pilot Project Launched to Improve Identification of FH Patients

Sqilline and Prof. Dr. Ivo Petrov’s team of leading cardiologists from Acibadem City Clinic Sofia have launched a pilot project to apply a Familial Hypercholesterolemia (FH) Identification Algorithm in patients with Acute Cardiovascular Events at the time of their hospitalization.

Cardiologists will work with the specially developed mobile and desktop application Danny Cardio. It will notify physicians of patients with a possible, probable, or definitive FH diagnosis based on a calculated result following the Dutch Lipid Clinic Network (DLCN) score.

Danny Cardio will organize all available data from multiple sources so physicians can approve/reject FH diagnosis while the patient is still in the hospital. 

AI & NLP algorithms will transform the free text into structured data. 

Smart notifications and direct link to FH Dutch Score will enhance communication between physicians working different shifts within the hospital.

The main objectives of the pilot project are:

  • Systematic screening during hospitalization 
  • Empower physicians with a clinical decision support tool
  • Improve patients’ treatment and future outcomes
  • Reduce the burden on the healthcare system by preventing recurrent event

Sqilline expects more than 15 leading cardiac hospitals in Bulgaria to join the project and start working with the new Danny Cardio application.

Share this article:

More News & Highlights

News

Accelerating Progress Toward a Bolder Vision for Medical Affairs with Next-Generation Technology

The pharmaceutical industry is undergoing a fundamental transformation. Traditionally, the key engines of innovation have been Research & Development (R&D) and Commercial. Yet, in recent...

Read more...

News

Bridging the Gap in Rare Disease Diagnosis: How Sqilline’s Danny Platform is Making a Difference

Rare diseases present one of the biggest challenges in modern healthcare. Affecting fewer than 5 in 10,000 people, these conditions often go undiagnosed for years,...

Read more...

News

Regulation and Innovation in Clinical Trials

The landscape of clinical trials is undergoing a profound transformation. On one hand, regulatory changes such as the full implementation of the Clinical Trials Regulation...

Read more...